Allergy Diagnostics Market Size Worth $ 13.71 Billion By 2032 | CAGR: 10.3%

Allergy Diagnostics Market Size Worth $ 13.71 Billion By 2032 | CAGR: 10.3%

The global allergy diagnostics market size is expected to reach USD 13.71 billion by 2032, according to a new study by Polaris Market Research. The report “Allergy Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Product & Services (Consumables, Instruments {Immunoassay Analyzers, ELISA Analyzers, Luminometers, Other Instruments}, Services); By Allergen Type; By Test Type; By End User; By Region; Segment Forecast, 2024 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The global allergy diagnostics market is driven growing prevalence of allergic conditions like atopic dermatitis, allergic conjunctivitis, and diverse food allergies. Food allergies creates adverse reactions immune system to certain foods. Global prevalence rate for food allergy is growing at 1-2%, with higher incidence among children 6-8%. Around, 90% of the food allergies caused by egg, shell-fish, nuts, soy, cow’s milk, fish, peanuts, and wheat.

Advanced diagnostics tests such as Basophil Activation Test (BAT) & mast cells can increase the accuracy of diagnosis, also providing insights regrading molecular mechanisms causing allergic reactions. In parallel, molecular diagnosis and OMICS approach will also complement diagnosis process. The consumer shift towards personalized medicines emphasizes the need for precise and customized diagnostic methods, which is driving the demand for allergy screening procedures. For instance, in March 2023, Thermo Fisher Scientific, launched the Allergy Microspot Test an advanced allergy microarray test enabling the simultaneous testing for over 100 allergens.

Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below:

Integration of predictive analytics and AI in the allergy diagnostics can enable analysis of large data-sets to predict disease outcomes. It uses historical data and AI based algorithms to analyze probability of developing allergies or to determine the effectiveness of medication outcome. Innovations such as, AI based image analysis & AI clinical assistants allows easy diagnosis and therapy suggestions via improved clinical workflow ensuring efficiency.

The fusion or integration of telemedicine with at-home allergy testing kits is enhancing accessibility and convenience for allergy diagnostics, particularly benefiting patients in remote or underserved regions. For instance, in June 2023, Everly Health launched at-home allergy testing kits paired with telemedicine consultations, enabling patients to collect samples at home and discuss results and treatment plans with a doctor remotely.

Allergy Diagnostics Market Report Highlights

  • Immunoassay analyzers sub-segment is anticipated to witness the highest growth in the forecast period, due to the growing range of applications.
  • In-haled Allergens segment garnered largest share, owing to the increasing pollen and environmental pollution.
  • In-vivo tests segment is projected to experience a larger revenue share, due to its efficiency, increased accessibility, and sensitivity.
  • Asia Pacific is expected to surge fastest growth during the forecast period, due to developing healthcare infrastructure, lifestyle changes and climatic conditions.
  • The global players include Astra Biotech GmbH, bioMérieux, Danaher & GA Generic Assays.

Polaris Market Research has segmented the Allergy Diagnostics market report based on products & services, allergen type; test type; end user, and region:

Allergy Diagnostics, Product & Services Outlook (Revenue - USD Billion, 2019 - 2032)

  • Consumables
  • Instruments
    • Immunoassay Analyzers
    • ELISA Analyzers
    • Luminometers
    • Other Instruments
  • Services

Allergy Diagnostics, Allergen Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Inhaled Allergens
  • Food Allergens
  • Drug Allergens
  • Others

Allergy Diagnostics, Test Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • In Vivo Tests
  • In Vitro Tests

Allergy Diagnostics, End User Outlook (Revenue - USD Billion, 2019 - 2032)

  • Diagnostic Laboratories
  • Hospital-based Laboratories
  • Academic Research Institutes
  • Others

Allergy Diagnostics, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Netherlands
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Indonesia
    • Malaysia
    • Australia
    • Rest of APAC
  • Latin America
    • Argentina
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Israel
    • South Africa
    • Rest of Middle East & Africa

Allergy Diagnostics Market Report Scope

Report Attributes


Market size value in 2024

USD 6.24 billion

Revenue forecast in 2032

USD 13.71 billion


10.3% from 2024 – 2032

Base year


Historical data

2019 – 2022

Forecast period

2024 – 2032

Quantitative units

Revenue in USD billion and CAGR from 2024 to 2032

Segments covered

  • By Product & Services
  • By Allergen Type
  • By Test Type
  • By End User
  • By Region

Regional scope

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Competitive Landscape

  • Allergy Diagnostics Market Share Analysis (2023)
  • Company Profiles/Industry participants profiling includes company overview, financial information, product/service benchmarking, and recent developments

Report Format

  • PDF + Excel


Report customization as per your requirements with respect to countries, region and segmentation.

For Specific Research Requirements

Request for Customized Report